These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 33262240)

  • 21.
    Kiedrowski MR; Gaston JR; Kocak BR; Coburn SL; Lee S; Pilewski JM; Myerburg MM; Bomberger JM
    mSphere; 2018 Aug; 3(4):. PubMed ID: 30111629
    [No Abstract]   [Full Text] [Related]  

  • 22. The treatment of respiratory pseudomonas infection in cystic fibrosis: what drug and which way?
    Banerjee D; Stableforth D
    Drugs; 2000 Nov; 60(5):1053-64. PubMed ID: 11129122
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bacterial sinusitis can be a focus for initial lung colonisation and chronic lung infection in patients with cystic fibrosis.
    Aanæs K
    J Cyst Fibros; 2013 Sep; 12 Suppl 2():S1-20. PubMed ID: 24064077
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination antimicrobial susceptibility testing for acute exacerbations in chronic infection of Pseudomonas aeruginosa in cystic fibrosis.
    Waters V; Ratjen F
    Cochrane Database Syst Rev; 2015 Nov; (11):CD006961. PubMed ID: 26522473
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Upper versus lower airway microbiome and metagenome in children with cystic fibrosis and their correlation with lung inflammation.
    Kirst ME; Baker D; Li E; Abu-Hasan M; Wang GP
    PLoS One; 2019; 14(9):e0222323. PubMed ID: 31536536
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multi-Omics Approaches: The Key to Improving Respiratory Health in People With Cystic Fibrosis?
    Lee AJ; Einarsson GG; Gilpin DF; Tunney MM
    Front Pharmacol; 2020; 11():569821. PubMed ID: 33013411
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microbiome in cystic fibrosis: Shaping polymicrobial interactions for advances in antibiotic therapy.
    Lopes SP; Azevedo NF; Pereira MO
    Crit Rev Microbiol; 2015; 41(3):353-65. PubMed ID: 24645634
    [TBL] [Abstract][Full Text] [Related]  

  • 28.
    Reece E; Doyle S; Greally P; Renwick J; McClean S
    Front Microbiol; 2018; 9():1205. PubMed ID: 29922270
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyanide Toxicity to Burkholderia cenocepacia Is Modulated by Polymicrobial Communities and Environmental Factors.
    Bernier SP; Workentine ML; Li X; Magarvey NA; O'Toole GA; Surette MG
    Front Microbiol; 2016; 7():725. PubMed ID: 27242743
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discerning the complexity of community interactions using a Drosophila model of polymicrobial infections.
    Sibley CD; Duan K; Fischer C; Parkins MD; Storey DG; Rabin HR; Surette MG
    PLoS Pathog; 2008 Oct; 4(10):e1000184. PubMed ID: 18949036
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microbiome in the pathogenesis of cystic fibrosis and lung transplant-related disease.
    Cribbs SK; Beck JM
    Transl Res; 2017 Jan; 179():84-96. PubMed ID: 27559681
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Developing a model for cystic fibrosis sociomicrobiology based on antibiotic and environmental stress.
    Lopes SP; Azevedo NF; Pereira MO
    Int J Med Microbiol; 2017 Dec; 307(8):460-470. PubMed ID: 29033313
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Viral-Bacterial Co-infections in the Cystic Fibrosis Respiratory Tract.
    Kiedrowski MR; Bomberger JM
    Front Immunol; 2018; 9():3067. PubMed ID: 30619379
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microenvironmental characteristics and physiology of biofilms in chronic infections of CF patients are strongly affected by the host immune response.
    Jensen PØ; Kolpen M; Kragh KN; Kühl M
    APMIS; 2017 Apr; 125(4):276-288. PubMed ID: 28407427
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tracking Polymicrobial Metabolism in Cystic Fibrosis Airways:
    Gao B; Gallagher T; Zhang Y; Elbadawi-Sidhu M; Lai Z; Fiehn O; Whiteson KL
    mSphere; 2018 Apr; 3(2):. PubMed ID: 29695623
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microbial ecology of the cystic fibrosis lung.
    Harrison F
    Microbiology (Reading); 2007 Apr; 153(Pt 4):917-923. PubMed ID: 17379702
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation of behaviour and virulence of a high alginate expressing Pseudomonas aeruginosa strain from cystic fibrosis by oral commensal bacterium Streptococcus anginosus.
    Waite RD; Qureshi MR; Whiley RA
    PLoS One; 2017; 12(3):e0173741. PubMed ID: 28301571
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interplay between host-microbe and microbe-microbe interactions in cystic fibrosis.
    Armbruster CR; Coenye T; Touqui L; Bomberger JM
    J Cyst Fibros; 2020 Mar; 19 Suppl 1(Suppl 1):S47-S53. PubMed ID: 31685398
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibiotics Drive Expansion of Rare Pathogens in a Chronic Infection Microbiome Model.
    Varga JJ; Zhao CY; Davis JD; Hao Y; Farrell JM; Gurney JR; Voit E; Brown SP
    mSphere; 2022 Oct; 7(5):e0031822. PubMed ID: 35972133
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypermutation in Burkholderia cepacia complex is mediated by DNA mismatch repair inactivation and is highly prevalent in cystic fibrosis chronic respiratory infection.
    Martina P; Feliziani S; Juan C; Bettiol M; Gatti B; Yantorno O; Smania AM; Oliver A; Bosch A
    Int J Med Microbiol; 2014 Nov; 304(8):1182-91. PubMed ID: 25217078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.